INTRACRANIAL STENTS - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Intracranial Stents in US$ Thousand. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 16 companies including many key and niche players such as -

Admedes Schuessler GmbH
BALT Extrusion
Cardiatis SA
Codman & Shurtleff, Inc.
Covidien PLC
ITGI Medical Ltd.


Click here to request a full list of companies covered in the report...

Code : MCP-7795
Price : $4500
Companies : 16
Pages : 88
Date : August 2013
Market Data Tables : 17

Complimentary Market Brief:


Request a Complimentary Copy of the Report Insights, Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS


 
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   A Prelude.....II-1
Recession in Retrospect and the Road Ahead.....II-1
2$200
   US FDA Restrictions on Use of Stryker’s Wingspan: A Major Blow to ICAD Stents
  Market.....II-3
1$100
   Aging Population to Propel Growth in Intracranial Stents Market.....II-4
Table 1: Elderly Population (65+ Years) as a Percentage of the Total Population: 2000 & 2025 (includes corresponding Graph/Chart).....II-4
1$350
   Table 2: Global Population Statistics for the 65+ Age Group: 2012 (includes corresponding Graph/Chart).....II-51$350
   Changing Lifestyle Conditions Stoking Risk of Cerebrovascular Diseases.....II-6
Startling Statistics of Stroke.....II-6
1$100
   Rising Number of Restenosis Cases Boosts Demand for Stenting.....II-7
Asians at Highest Risk of Intracranial Atherosclerosis Disease.....II-7
Cardiovascular Stent Manufacturers Diversify Into the Neurovascular Market.....II-7
1$100
   QMRA Facilitates Detection of In-stent Stenosis.....II-8
MNCs Weave Strategies to Tap Growth Centers in Emerging Markets.....II-8
1$100
   Medical Tourism Buoys Demand for Stenting Procedures in Emerging Nations.....II-9
Challenges in Product Development and Commercialization Moderate Market Growth.....II-9
1$100
   Technological Challenges.....II-10
Safety and Efficacy.....II-10
Regulatory Challenges.....II-10
Price Factor.....II-10
Rising Road Accidents Lead to Increasing Number of Stenting Procedures.....II-10
1$100
   Table 3: Global Rate of Road Fatalities by Economic Status of Countries (2013): Percentage Rate of Road Fatalities per 100,000 Residents for Low, Mid and High Per Capita Income Regions (includes corresponding Graph/Chart).....II-111$350
   Intracranial Stents.....II-12
Intracranial Stenting.....II-12
Glossary of Physical Characteristics of Stents.....II-12
1$100
   Evolution.....II-13
Types of Stents.....II-13
Bare Metal Stents (BMS).....II-13
1$100
   Drug Eluting Stents.....II-14
Self-Expanding Stents.....II-14
1$100
   A Brief Review of the Intracranial Stenting Systems Available in the
  Marketplace.....II-15
Neuroform.....II-15
Neuroform EZ® Stent System.....II-15
Wingspan Stent System.....II-15
1$100
   SELF-EXPANDAPLE LEO.....II-16
Micrus® Pharos™ Vitesse™ Intracranial Stent.....II-16
1$100
   Neurolink System®.....II-17
Solitaire™ FR Revascularization Device.....II-17
Solitaire AB Neurovascular Remodeling Device.....II-17
Cordis Enterprise Vascular Reconstruction Device and Delivery System.....II-17
The Pipeline Stent.....II-17
1$100
   Other Procedures.....II-18
Flow Diverters.....II-18
Silk™.....II-18
Pipeline Embolization Device (PED).....II-18
Post-Treatment Management.....II-18
Anti-Platelet Therapy.....II-18
1$100
   Surveillance Imaging.....II-191$100
   Introduction.....II-20
Ischemic Stroke.....II-20
Symptoms, Indications and Complications Associated with Strokes.....II-20
Posterior Circulation Strokes.....II-20
Anterior Circulation Strokes.....II-20
1$100
   Non-Specific Signs.....II-21
Complications.....II-21
Some Major Risk Factors of Strokes.....II-21
1$100
   Intracranial Stenosis.....II-22
Diagnosis of Intracranial Stenosis.....II-22
Differential Diagnosis.....II-22
1$100
   Screening.....II-23
Anatomic Diagnosis.....II-23
Digital Subtraction Angiography.....II-23
Transcranial Doppler.....II-23
Magnetic Resonance Angiography (MRA).....II-23
1$100
   Positron Emission Tomography (PET).....II-24
Computerized Tomography (CT) Perfusion.....II-24
Treatment Procedures for Intracranial Stenosis.....II-24
Medication.....II-24
Anticoagulants or Blood Thinners.....II-24
Cholesterol Lowering Drugs.....II-24
Blood Pressure Medications.....II-24
1$100
   Surgical Procedures.....II-25
Stenting/Balloon Angioplasty.....II-25
Cerebral Artery Bypass.....II-25
Major Neurovascular Indications Requiring Stenting Procedures.....II-25
Intracranial Atherosclerotic Disease (ICAD).....II-25
1$100
   Risk Factors.....II-26
Treatment Options for ICAD.....II-26
Brain Aneurysms/ Cerebral Aneurysm/ Intracranial Aneurysm.....II-26
Aneurysm – Quick Facts.....II-26
1$100
   Symptoms of Unruptured Aneurysm.....II-27
Risk Factors for Aneurysm.....II-27
Detection Methods.....II-27
1$100
   Table 4: Comparison of Sensitivity and Specificity of Computed Tomography Angiography (CTA), Transcranial Doppler Sonography (TCD) and Magnetic Resonance Angiography (MRA) in the Diagnosis of Intracranial Aneurysms (includes corresponding Graph/Chart).....II-28

Table 5: Percentage Mortality, Morbidity and Re-bleeding Rate of Intervention Associated with Intracranial Aneurysms.....II-28
Arterial Dissections.....II-28
1$350
   Diagnosis.....II-29
Treatment.....II-29
Restenosis.....II-29
1$100
   MicroPort’s WILLIS® Intracranial Stent Graft System Receives China SFDA
  Approval.....II-30
Phenox’s pCONus Bifurcation Aneurysm Implant Obtains CE-Mark Approval.....II-30
Acandis’ Acclino 1.9-F Stent System Receives CE Mark Approval.....II-30
1$100
   ITGI Medical Obtains CE Mark Approval for AneuGraftNx.....II-31
Micrus Endovascular Obtains FDA Approval for VISSIT Clinical Trial.....II-31
Reverse Medical Obtains CE Mark for ReFlex A+ Catheter.....II-31
1$100
   Boston Scientific Introduces Neuroform EZ™ Stent System.....II-32
Codman & Shurtleff Obtains Approval for Vascular Reconstruction Device and Delivery
  System in Japan.....II-32
Reverse Medical Obtains CE Mark Approval for RePort Guide Catheter System.....II-32
1$100
   STAR Study Results Establish Safety and Efficacy of Solitaire™ FR Device in Acute
  Ischemic Stroke Treatment.....II-33
MicroPort Scientific Announces Inauguration of MicroPort NeuroTech.....II-33
Admedes Schuessler to Expand Nitinol Manufacturing Capacity.....II-33
1$100
   Purdue University Scientists Study Stents Coated with Nanotechnology-Enhanced Drug
  for Treatment of Aneurysms.....II-34
Boston Scientific Divests Neurovascular Business to Stryker.....II-34
NeuroSigma and UCLA Enter into Exclusive License Contract.....II-34
1$100
   Johnson & Johnson Takes Over Micrus Endovascular.....II-35
Covidien Takes Over ev3.....II-35
Bayer MaterialScience Completes Acquisition of PolyBioMed.....II-35
2$200
   Admedes Schuessler GmbH (Germany).....II-37
BALT Extrusion (France).....II-37
Cardiatis SA (Belgium).....II-37
1$100
   Codman & Shurtleff, Inc. (US).....II-38
Covidien PLC (Ireland).....II-38
1$100
   ITGI Medical Ltd. (Israel).....II-391$100
   Medtronic, Inc. (US).....II-40
MicroPort Scientific Corporation (China).....II-40
OBEX Medical (New Zealand).....II-40
1$100
   Penumbra, Inc. (US).....II-41
Stryker Corporation (US).....II-41
2$200
   Table 6: World Recent Past, Current & Future Analysis for Intracranial Stents by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2010 through 2018 (includes corresponding Graph/Chart).....II-431$350
   Table 7: World Historic Review for Intracranial Stents by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2005 through 2009 (includes corresponding Graph/Chart).....II-441$350
   Table 8: World 14-Year Perspective for Intracranial Stents by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for the Years 2005, 2013 & 2018 (includes corresponding Graph/Chart).....II-451$350
   A. Market Analysis.....III-1
Current and Future Analysis.....III-1
Regulatory Status of Intracranial Stents in the United States.....III-1
Intracranial Stenting among Medicare Beneficiaries during the Years
  2006-2010.....III-1
Product Introductions & Approvals.....III-1
1$90
   Strategic Corporate Developments.....III-22$180
   Key Players.....III-42$180
   B. Market Analytics.....III-6
Table 9: US Recent Past, Current & Future Analysis for Intracranial Stents Market Analyzed with Annual Sales Figures in US$ Thousand for the Years 2010 through 2018 (includes corresponding Graph/Chart).....III-6

Table 10: US Historic Review for Intracranial Stents Market Analyzed with Annual Sales Figures in US$ Thousand for the Years 2005 through 2009 (includes corresponding Graph/Chart).....III-6
1$200
   A. Market Analysis.....III-7
Current and Future Analysis.....III-7
European Neurosurgicals Market Poised to Grow At a Slow Pace.....III-7
Focus on Select Regional Markets.....III-7
France.....III-7
French Government Imposes Regulations on Advertisement of High-risk Medical
  Devices.....III-7
1$90
   The United Kingdom.....III-8
Stroke Statistics in the UK.....III-8
Table 11: Breakdown of Total Number of Deaths Due to Strokes by Age and Sex in the UK for the Year 2010 (includes corresponding Graph/Chart).....III-8
1$200
   Product Introductions & Approvals.....III-91$90
   Strategic Corporate Developments.....III-101$90
   Key Players.....III-112$180
   B. Market Analytics.....III-13
Table 12: European Recent Past, Current & Future Analysis for Intracranial Stents Market Analyzed with Annual Sales Figures in US$ Thousand for the Years 2010 through 2018 (includes corresponding Graph/Chart).....III-13
1$200
   Table 13: European Historic Review for Intracranial Stents Market Analyzed with Annual Sales Figures in US$ Thousand for the Years 2005 through 2009 (includes corresponding Graph/Chart).....III-141$200
   A. Market Analysis.....III-15
Current and Future Analysis.....III-15
Price Sensitivity of Asian Consumers Hinders Market Growth.....III-15
Focus on Select Regional Markets.....III-15
Australia.....III-15
Pertinent Stroke-related Statistics in Australia.....III-15
Table 14: Stroke Prevalence in Australia by Age and Gender for the Year 2012 (includes corresponding Graph/Chart).....III-15
1$200
   Leading Risk Factors Responsible for Stroke-Related Fatalities Ranked on the
  Basis of Number of Deaths (2012).....III-16
China.....III-16
Healthcare Reforms to Propel Stent Market.....III-16
Table 15: Leading Brands in the Chinese Intracranial Stents Market (2012): Percentage Breakdown of Market Share for Apollo and Others (includes corresponding Graph/Chart).....III-16
WILLIS® to Target Bright Market Prospects in China.....III-16
1$200
   India.....III-17
Stroke 'At a Glance'.....III-17
Changes in Lifestyle Demographic and Socioeconomic Factors Increase Stroke
  Prevalence.....III-17
Management and Treatment of Stroke Presents a Daunting Task.....III-17
1$90
   Kerala – The New Global Hub for Neurovascular Therapy.....III-18
Japan.....III-18
Studies Validate Effectiveness of Endovascular Therapy for Treatment of
  Intracranial Aneurysm.....III-18
1$90
   Factors Impacting Japanese Intracranial Stents Market.....III-19
Product Introductions & Approvals.....III-19
2$180
   Strategic Corporate Development.....III-21
Key Players.....III-21
2$180
   B. Market Analytics.....III-23
Table 16: Rest of World Recent Past, Current & Future Analysis for Intracranial Stents Market Analyzed with Annual Sales Figures in US$ Thousand for the Years 2010 through 2018 (includes corresponding Graph/Chart).....III-23
1$200
   Table 17: Rest of World Historic Review for Intracranial Stents Market Analyzed with Annual Sales Figures in US$ Million for the Years 2005 through 2009 (includes corresponding Graph/Chart).....III-241$200
  
Total Companies Profiled: 16 (including Divisions/Subsidiaries - 18)

Region/Country Players

The United States 7 Europe 6 France 1 Germany 3 Rest of Europe 2 Asia-Pacific (Excluding Japan) 4 Middle East 1
Click here to request a full table of contents and more details on this project.